I

Instituto Rosenbusch SA
BCBA:ROSE

Watchlist Manager
Instituto Rosenbusch SA
BCBA:ROSE
Watchlist
Price: 222.5 ARS -2.2%
Market Cap: 9.5B ARS

Operating Margin
Instituto Rosenbusch SA

21.5%
Current
11%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
21.5%
=
Operating Profit
1.3B
/
Revenue
6.1B

Operating Margin Across Competitors

No Stocks Found

Instituto Rosenbusch SA
Glance View

Market Cap
9.5B ARS
Industry
Pharmaceuticals

Instituto Rosenbusch SA engages in the manufacture and marketing of veterinary products. The company is headquartered in Buenos Aires, Buenos Aires. The company went IPO on 2008-02-21. The firm's products are structured in two lines: Pharmaceutical, including antibiotics, antimastitics products, antimycotics, antiparasites, vitamins, minerals and other chemotherapies, and Biological, comprising vaccines for cattle, equines, porks and sheeps and dogs. The company is also involved in the slaughtering and provision of meat products. As of December 31, 2011, the Company owned such subsidiaries as Laboratorios Rosenbusch SA, Laboratorios Bolivar SA and Rosenbusch Paraguay SA.

ROSE Intrinsic Value
Not Available
I
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
21.5%
=
Operating Profit
1.3B
/
Revenue
6.1B
What is the Operating Margin of Instituto Rosenbusch SA?

Based on Instituto Rosenbusch SA's most recent financial statements, the company has Operating Margin of 21.5%.

Back to Top